One person, one family, one community at a time, the Hunter Medical Research Institute (HMRI) fights the illnesses affecting lives throughout the world. Our translational research model aligns over 1500 researchers, students and support staff from Hunter New England Health and the University of Newcastle, inspiring new discoveries to deliver a healthier future.

Throughout Newcastle and the Hunter region researchers, students and support staff are working across six HMRI Research Programs to prevent, cure and treat a diverse range of serious illnesses by translating research findings made in the laboratory into real health treatments and preventative strategies. Internationally-recognised research outcomes are being achieved in asthma and airway diseases, cancer, diabetes, mental health, nutrition, pregnancy and reproduction, stroke and more. Collaborations are being conducted with institutes on all points of the globe.

HMRI provides vital funding and facilities to fuel research, but the heart and soul of the Institute are people – the researchers, the generous donors and supporters, the committed volunteers, and the patients who participate in trials and ultimately benefit from the research results.

Upcoming Events

Costa Rica Coast2Coast Challenge
Costa Rica Coast2Coast Challenge
March 1, 2021 - 9:00am to March 31, 2021 - 5:00pm

A team of 20 Borne HMRI supporters will embark on a unique, off-the-beaten-track adventure across Costa Rica.

Latest News & Articles

Jun 2 2020

Researchers from the University of Newcastle, Hunter Medical Research Institute and Hunter New England Health have excelled in the latest round of National Health and Medical Research Council (NHMRC) funding, attracting more than $860,000 to analyse the physiological and mental health effects of hazardous bushfire smoke.

Jun 1 2020

A new auto-injecting pen will allow patients with severe eosinophilic asthma patients to self-administer a drug known as Mepolizumab, with reimbursement under the PBS.

May 25 2020

Professor Coralie English and team have adapted to COVID-19, and this current trial reflects that. She explains how the i-REBOUND trial is looking at providing expert support for exercise (moving more) and diet (eating well) after stroke.